Structural basis for 18-beta-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor
Zhang, H., Huang, Q., Zhai, J., Zhao, Y.N., Zhang, L.P., Chen, Y.Y., Zhang, R.W., Li, Q., Hu, X.P.(2015) Acta Pharmacol Sin 36: 1145-1150
- PubMed: 26279158 
- DOI: https://doi.org/10.1038/aps.2015.59
- Primary Citation of Related Structures:  
4PV5 - PubMed Abstract: 
Glyoxalase I (GLOI), a glutathione (GSH)-dependent enzyme, is overexpressed in tumor cells and related to multi-drug resistance in chemotherapy, making GLOI inhibitors as potential anti-tumor agents. But the most studied GSH analogs exhibit poor pharmacokinetic properties. The aim of this study was to discover novel non-GSH analog GLOI inhibitors and analyze their binding mechanisms.
Organizational Affiliation: 
School of Pharmaceutical Sciences & Centre for Cellular and Structural Biology of Sun Yat-sen University, Guangzhou 510006, China.